Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Reichelt

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Psychiatry and Clinical Neurosciences|October 2, 2024
Impact of psilocybin on cognitive function: A systematic reviewShakila Meshkat, Triana Juliana Tello-Gerez, Fatemeh Gholaminezhad, et al.
Neuroscience and Biobehavioral Reviews|April 17, 2025
Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic reviewShakila Meshkat, Gunjan Malik, Richard J Zeifman, et al.
Brain and Behavior|July 10, 2025
Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic ReviewShakila Meshkat, Corinna Di Luciano, Alyssa Swiderski, et al.
Pharmaceutics|April 26, 2025
Pharmacokinetics of Psilocybin: A Systematic ReviewShakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2026
Magnitude of Response in Treatment and Control Groups within Psychedelic Trials for Psychiatric Disorders: A Meta-AnalysisShakila Meshkat, Qiaowei Lin, Rachel Sousa-Ho, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Psychiatry and Clinical Neurosciences|October 2, 2024
Impact of psilocybin on cognitive function: A systematic reviewShakila Meshkat, Triana Juliana Tello-Gerez, Fatemeh Gholaminezhad, et al.
Neuroscience and Biobehavioral Reviews|April 17, 2025
Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic reviewShakila Meshkat, Gunjan Malik, Richard J Zeifman, et al.
Brain and Behavior|July 10, 2025
Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic ReviewShakila Meshkat, Corinna Di Luciano, Alyssa Swiderski, et al.
Pharmaceutics|April 26, 2025
Pharmacokinetics of Psilocybin: A Systematic ReviewShakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2026
Magnitude of Response in Treatment and Control Groups within Psychedelic Trials for Psychiatric Disorders: A Meta-AnalysisShakila Meshkat, Qiaowei Lin, Rachel Sousa-Ho, et al.
Pageof 9